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ABSTRACT 
Background: The effect of body mass index (BMI) on the incidence and prevalence of airway obstructive diseases-
asthma, chronic bronchitis, and emphysema—is not clear. The nature of the relationship between BMI and airway 
obstructive diseases are also complicated by the potential effect respiratory symptoms can have on appetite and 
physical activity. Aims: Proposed study was to find out the association between body mass index and lung functions 
in females with Non-obstructive airway disease identified by spirometric protocols. Materials and Methods: A 
retrospective analysis of the spirometry data obtained between August 2018 and January 2019 was conducted in the 
Physiology Department, B. S. Medical College, Bankura for six months. In this study above 200 test results over 
female subjects were taken from study database. Out of those 138 test results of Non-obstructive airway disease 
were included considering inclusion and exclusion criteria. Results: The Study shows PEFR and FEF75% have 
significant positive correlation with BMI of underweight. But in normal subject’s significant positive correlation 
between FEV1/FVC, FEF25-75%, PEFR, PIFR, FEF25%, and FEF50% with BMI were observed.  In overweight 
there were significant negative correlation observed between FEV1, FEF25-75%, PIFR and FEF50% with BMI. 
Conclusion: Our study showed that clear association was found between pulmonary function parameters and BMI 
in females with non-obstructive airway disease. 
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INTRODUCTION 
In India, not only obesity but also undernutrition is 
prevalent. Undernutrition is not a disease state and can 
be managed with proper nutritional therapy.[1] On the 
other hand, obesity is a global problem and it is a 
significant contributor to morbidity and mortality.[2] 
The effect of body mass index (BMI) on the incidence 
and prevalence of airway obstructive diseases -asthma,  
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chronic bronchitis, and emphysema- is not clear. The 
nature of the relationship between BMI and airway 
obstructive diseases are also complicated by the 
potential effect respiratory symptoms can have on 
appetite and physical activity. For example, subjects 
with airway obstructive diseases may be more likely to 
avoid exercise, adopt a sedentary lifestyle and, in turn, 
gain weight. An association between obesity and 
asthma has been reported widely, with disparity 
between males and females. The magnitude of increase 
in obesity has been paralleled by an increase in the 
prevalence of asthma in many global locales.[2,3] 
A study done by Beuther and Sutherland the effect of 
elevated body mass index (BMI) on asthma incidence 
determined that the likelihood of asthma was 1.51 
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times higher in subjects with a BMI ≥ 25 kg/m2 
compared to those of a normal weight (18.5-24.9 
kg/m2) {Odds Ratio (OR) 1.51, 95% CI, 1.17-1.62}.[4] 
Various studies are also suggestive of an increased 
prevalence of obesity amongst adults with asthma, but 
do not adequately describe any cause and effect 
relationship between the obesity and asthma.[5,6,7] 
Various studies that investigated the association of 
obesity and airway responsiveness where the 
association between asthma and obesity was not 
found.[8,9,10] The relationship to an abnormal BMI has 
been more extensively studied for asthma than COPD. 
Higher levels of BMI and higher proportions of obese 
subjects have been found among patients with asthma 
than control subjects in adult populations.[11,12] 
Proposed study was to find out the associationbetween 
body mass index and lung functions in females with 
Non-obstructive airway disease identified by 
spirometric protocols. 
 
MATERIAL AND METHODS 
In this study above 200 test results over female subjects 
were taken from study database. Out of those 138 test 
results of non-obstructive airway disease were included 
considering inclusion and exclusion criteria. Written 
informed consent from every patient was already taken. 
Ethical approval was granted by the Ethics committee 
of Bankura Sammilani Medical College, Bankura, 
West Bengal. 
Experimental Protocol: A retrospective analysis of 
the spirometry data obtained between August 2018 and 
January 2019 was conducted in the Physiology 
Department, B. S. Medical College, Bankura for six 
months. Patients were selected from those participants, 
referred to the pulmonary function laboratory in the 
Department of Physiology by a variety of medical 
specialties including Chest Medicine, General 
Medicine, Paediatric medicine General Surgery, 
Gynaecology, Oncology, etc. The treatment sheets of 
every patient referred by physicians were consulted for 
their relevant history, examination finding, and 
investigation so also the pulmonary functions test 
results. The cases under review were selected on the 
basis of : a) < 12% improvement in FEV1 after 
reversibility test, b) FEV1 ≥ 80% of predicted without 
reversibility test and c) FEV1 < 80% of predicted but 
with FEV1/FVC ≥ 70% of predicted without 
reversibility test. The exclusion criteria were a) ≥ 12% 
improvement in FEV1 after reversibility test b) FEV1 
< 80% of predicted without reversibility test and c) 
FEV1 < 80% of predicted and FEV1/FVC < 70% of 
predicted without reversibility test, d) subjects with any 
cardiac ailments.  
 
Measurement of Anthropometric parameters 
Weight was measured using a standardized electronic 
weighing machine, with the subjects standing without 
footwear, carrying any bagwith light clothes. The 
height of the subjects were measured to the nearest 
centimetre using stadiometer, Body Mass Index (BMI) 
was calculated by using Quetlet’s index (body weight 
in kg/height in m2).[13] Depending on their BMI values, 
the subjects were classified into underweight 
(BMI<18.5kg/m2, n=21), normal (18.5 to <25kg/m2, 
n=63) and overweight (>25kg/m2, n=54) groups 
according to BMI ranges as per WHO classification 
system.[2] 
Measurement of the Pulmonary Functions 
Pulmonary functions were measured by the electronic 
spirometer, model-RMS Helios-702 in accordance with 
the standards of lung function testing of the American 
Thoracic Society/European Respiratory Society 
(ATS/ERS).[14]Test was measure between 10 a.m. to 12 
p.m. to avoid any circadian rhythm. The subjects were 
asked to avoid beverages like tea, coffee and other 
stimulants and to report on a light breakfast. The test 
was explained and demonstrated to the subjects. After a 
rest for 5–10 minutes, the test was carried out. The best 
of the three acceptable results was selected. Post 
bronchodilator (reversibility test) testing was 
performed 10 minutes after administration of the 
bronchodilator. Pulmonary function report included 
patient’s gender, height, weight, age and smoking 
status. Standard spirometric measures included, forced 
vital capacity (FVC), forced expiratory volume in one 
second FEV1, the ratio of forced expiratory volume in 
one second to forced vital capacity (FEV1/FVC), 
Forced Expiratory Flow in 25-75% (FEF25%-
75%),Peak Expiratory Flow Rate (PEFR), Peak 
Inspiratory Flow Rate (PIFR), Forced Expiratory Flow 
in 25% (FEF25%), Forced Expiratory Flow in 50% 
(FEF50%) and Forced Expiratory Flow in 75% 
(FEF75%). Pulmonary function variables were 
recorded as a percentage of the normal value predicted 
on reported height and age.[15] 
Statistical Analysis 
Descriptive data analysis included the use of Mean and 
Standard Deviation was done. Data were analysed by 
SPSS (Statistical Package for Social Sciences) 
statistical software version 22 using proper statistical 
test. Differences were considered statistically different 
when p< 0.05. 
RESULTS 
Descriptive analysis was done of pulmonary function 
parameters of all female. Mean and standard deviation 
of female were calculated [Table 1]. Pulmonary 
function parameters were slightly higher in normal 
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comparison to underweight and overweight (except 
PIFR). 
[Table 2] shows PEFR and FEF75% have significant 
positive correlation with BMI of underweight and there 
is lack of association between FVC, FEV1, 
FEV1/FVC, FEF25-75%, PIFR, FEF25%, and FEF 
50%  with BMI. But in normal subject’s significant 
positive correlation between FEV1/FVC, FEF25-75%, 
PEFR, PIFR, FEF25%, and FEF50% with BMI were 
observed.  There is lack of association between FVC, 
FEV1, and FEF75% with BMI [Table 2]. In 
overweight there were significant negative correlation 
observed between FEV1, FEF25-75%, PIFR and 
FEF50% with BMI. There is lack of association 
between FVC, FEV1/FVC, PEFR, FEF25% and 
FEF75% with BMI [Table 2].  
 
Table 1: Mean and standard deviation of pulmonary function parameters of all females 
Pulmonary 
function 
parameters 
of all female 
(n=138) 
Underweight 
(n=21) 
(BMI<18.5kg/m2
) 
Normal weight(n=63) 
(BMI 18.5 to 
<25kg/m2)  
Overweight(n=54) 
(BMI > 25kg/m2) 
Mean + SD Mean + SD Mean + SD 
FVC (L) 1.78 + 0.31 2.10 + 0.48 2.05 + 0.34 
FEV1 (L) 1.59 + 0.18 1.93 + 0.52 1.79 + 0.27 
FEV1/FVC (%) 90.84 + 8.02 91.37 + 7.40 87.55 + 5.83 
FEF 25-75 (L/s) 2.17 + 0.56 2.63 + 0.99 2.19 + 0.51 
PEFR (L/s) 4.53 + 0.82 4.53 + 1.05 4.24 + 1.45 
PIFR (L/s) 2.87 + 0.67 2.43 + 1.04 2.57 + 1.20 
FEF 25% (L/s) 3.96 + 0.78 4.15 + 1.02 3.68 + 0.98 
FEF 50% (L/s) 2.61 + 0.59 3.03 +1.03 2.61 + 0.63 
FEF 75% (L/s) 1.17 + 0.48 1.47 + 0.72 1.14 + 0.41 
 
Table 2: Correlation between Pulmonary function parameters and Body mass index (BMI) of all females 
 
Correlation of Pulmonary function parameters 
with Body mass index(BMI) of all female (n=138) 
Pearson Correlation 
Coefficient(r) 
p value 
Underweight (n=21) 
(BMI<18.5kg/m2) 
FVC (L) .081 0.728 
FEV1 (L) .177 0.443 
FEV1/FVC (%) .092 0.691 
FEF 25-75 (L/s) .105 0.652 
PEFR (L/s) .466* 0.033 
PIFR (L/s) .282 0.215 
FEF 25% (L/s) .239 0.298 
FEF 50% (L/s) .161 0.486 
FEF 75% (L/s) .029 0.001 
Normal 
weight (n=63) 
(BMI 18.5 to <25kg/m2) 
 
FVC (L) -.215 0.090 
FEV1 (L) -.096 0.453 
FEV1/FVC (%) .388** 0.002 
FEF 25-75 (L/s) .269* 0.003 
PEFR (L/s) .356** 0.004 
PIFR (L/s) .295* 0.019 
FEF 25% (L/s) .391** 0.002 
FEF 50% (L/s) .276* 0.029 
FEF 75% (L/s) .150 0.241 
Overweight (n=54) 
BMI > 25kg/m2) 
FVC (L) -.243 0.077 
FEV1 (L) -.320* 0.018 
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FEV1/FVC (%) -.132 0.342 
FEF 25-75 (L/s) -.297* 0.029 
PEFR (L/s) -.150 0.280 
PIFR (L/s) -.598** 0.000 
FEF 25% (L/s) -.203 0.142 
FEF 50% (L/s) -.371** 0.006 
FEF 75% (L/s) -.178 0.197 
 
DISCUSSION 
 
The result of this study indicated a significant positive 
correlation between lung functions in terms of PEFR 
and FEF75% with BMI in underweight individual. 
Undernutrition is responsible for decrease in expiratory 
and inspiratory muscle mass, thus weakening the 
respiratory muscle. Weaker respiratory muscle 
diminishes the ventilatory capacity. Undernutrition also 
decreases the defence mechanism of respiratory 
system.[16] Ong et al. also studied the lung functions in 
malnourished children, and they found that there is a 
positive correlation between lung function and body 
weight.[17] There was no significant correlation between 
BMI and pulmonary function test parameters in normal 
and overweight boys. This result is concordant with the 
study of Muralidhara and Bhat who also found no 
significant correlation between BMI and pulmonary 
function.[18] However, the result of this study is not 
corroborative with the result of Wannamethee et al. 
who found inverse relationship between BMI and most 
pulmonary function in overweight and obese 
individuals.[19] 
Recent findings from the Baltimore Longitudinal Study 
of Aging suggest that low BMI could itself be a risk 
factor for COPD.[20] In another study, underweight 
patients with COPD were found to have lower carbon 
monoxide diffusing capacity and higher dyspnea scores 
than normal weight patients with COPD.[21] These 
characteristics are traditionally attributed primarily to 
the more emphysematous form of COPD.[22] 
Emphysema patients can progressively lose weight due 
to several mechanisms. For instance, it has been 
hypothesized that the oxygen cost of breathing is 
increased in these patients and the caloric intake is 
reduced since large meals can induce shortness of 
breath.[23, 24]The effects of obesity on spirometric 
values are not consistent in most of the studies, some 
studies showing significant effects [25-28] and some 
other studies showing no effects.[29,30,31] This 
discrepancy between studies could be explained by the 
wide variations in ethnicity of different population in 
PFT values or this may be a result of methodological 
differences in these studies. Our study significant 
positive correlation between FEV1/FVC, FEF25-75%, 
PEFR, PIFR, FEF25%, and FEF50% with BMI were 
observed in normal females. The compromised FVC, 
FEV1, FEV1/FVC, and uncompromised expiratory 
flow rates together suggestive of the dominant effects 
of increasing BMI on chest wall restriction and 
diaphragmatic limitation. We have also allowed for the 
isolation of this effect by inclusion of only non-
obstructive airway disease participants. If obstructive 
airway disease like asthma, chronic bronchitis were 
present in this subject pool, then we anticipate that 
airway obstruction would be exaggerated by the 
reduced lung volumes. Our findings demonstrate a 
marginal increase in airflow secondary to chest wall 
impedance. 
Study show significant negative correlation between 
FEV1, FEF25-75%, PIFR and FEF50% with BMI in 
overweight females. Schoenberg et al. reported that 
increase in muscle mass initially increases the 
pulmonary functions, but subsequent increase in weight 
may actually restrict the chest wall movement and thus 
may decrease the parameters.[32]The result of our study 
supports the study by Saxena et al., who found 
insignificant group difference between normal and over 
weight participants.[33] 
A study done by Guerra and Sherrill et al. conclude 
that Emphysema is associated with being underweight; 
asthma and chronic bronchitis are associated with 
being pre-obese or obese. The temporal sequence 
between smoking, abnormal BMI, and development of 
emphysema or chronic bronchitis is complex to assess. 
In contrast, the development of asthma seems to be 
temporally associated to a BMI >28, as patients with 
asthma are more likely to be obese both after and 
before the onset of respiratory symptoms.[34] 
 
CONCLUSION 
In conclusion, our study showed that clear association 
was found between pulmonary function parameters and 
BMI in females with non-obstructive airway disease. 
Undernutrition is responsible for decrease in expiratory 
and inspiratory muscle mass, thus weakening the 
respiratory muscle. Weaker respiratory muscle 
diminishes the ventilatory capacity, whereas 
subsequent increase in weight may actually restrict the 
chest wall movement and that may causes significance 
changes the some parameters of pulmonary function. 
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